#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small cell lung cancer Dent's disease Bronchopulmonary dysplasia Ovarian epithelial cancer Adult T-cell lymphoma/leukaemia refractory Myocarditis Pulmonary tuberculosis Aspergillus infection Mantle cell lymphoma stage II Penile cancer Fatty acid oxidation disorder Retinopathy proliferative Alveolar rhabdomyosarcoma Chronic myelomonocytic leukaemia Familial hypertriglyceridaemia More trials…

    Learn about Rare Diseases

    KBG syndrome – Basic Information Marfan’s syndrome – Treatment Mantle cell lymphoma stage IV – Diagnostics Splenic marginal zone lymphoma – Life with Disease Alagille syndrome – Diagnostics Paroxysmal nocturnal haemoglobinuria Hairy cell leukaemia – Life with Disease Haemophagocytic lymphohistiocytosis Factor VIII deficiency – Treatment Nephroblastoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Skin Autograft Fenoterol Hydrobromide Nalbuphine Hydrochloride Betamethasone Paroxetine Hydrochloride ALXN1920 Futibatinib Golimumab Ivonescimab Topiramate Tumour Detection Lutikizumab Bdc-1001 Marstacimab GSKVX000000034798 Pabinafusp Alfa Ivacaftor Tacrolimus IHMA-2121771-2 Losartan More therapies…

    Learn about Your Condition

    Squamous cell carcinoma Frontotemporal dementia Cholestatic pruritus Tendon injury Ischaemic skin ulcer Spinal osteoarthritis Haemorrhage prophylaxis Placenta praevia Postprandial hypoglycaemia Tertiary adrenal insufficiency Post procedural hypotension Appendicitis Organ donor Pigmentary glaucoma Eyelid ptosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Velocity Clinical Research Luebeck GmbH

Velocity Clinical Research Luebeck GmbH

Demmeringstrasse 47-49, Altlindenau, Luebeck, 04177, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Bi 690517
    • Empagliflozin
    Belgium Bulgaria Czechia Germany Hungary Italy +5

  • Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Salbutamol
    • Glycopyrronium Bromide
    • Budesonide
    Austria Bulgaria Czechia Denmark Finland France +10

  • A study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.

    Recruiting

    3 1 1
    Investigated Drugs:
    • Depemokimab
    • Salbutamol Sulfate
    Belgium Bulgaria Denmark France Germany Greece +6

  • Randomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Azd5004
    • Dapagliflozin
    Bulgaria Czechia Denmark Finland France Germany +8

  • Testing WIN378 Safety and Effects in Adults with Moderate or Severe Asthma

    Recruiting

    2 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • HUMAN IGG1 MONOCLONAL ANTIBODY AGAINST TSLP
    Bulgaria France Germany Spain Sweden

  • Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial

    Recruiting

    3 1 1
    Investigated Drugs:
    • Pelacarsen
    Austria Belgium Bulgaria Czechia Denmark France +14

  • Efficacy and safety of the investigational mRNA influenza vaccine gskvx000000077430 (drug combination) in adults ≥ 65 years

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Influenza
    Investigated Drugs:
    • INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED
    • Influenza A/Victoria/4897/2022 Ivr-238 (H1N1), Inactivated
    • Influenza Virus B/Michigan/01/2021
    Belgium Finland Germany Spain

  • Efficacy and Safety of Olatorepatide in Adults with Overweight or Obesity and Type 2 Diabetes

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Overweight
    • Type 2 diabetes mellitus
    Germany Hungary Poland Romania Spain

  • Long‑term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity and Type 2 Diabetes

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Maridebart Cafraglutide
    Bulgaria Czechia Germany Hungary Italy Poland

  • Phase 3 Extension Trial Evaluating Long‑Term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity

    Not yet recruiting

    3 1
    Investigated Drugs:
    • Maridebart Cafraglutide
    Belgium Czechia Denmark Finland Germany Italy +2
Previous Page
1 2 3 4 5 … 7
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!